The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Regulatory News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 135.00
Ask: 140.00
Change: 10.00 (7.84%)
Spread: 5.00 (3.704%)
Open: 127.50
High: 137.50
Low: 127.50
Prev. Close: 127.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

19 Nov 2019 11:05

RNS Number : 9150T
Faron Pharmaceuticals Oy
19 November 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMLLFILLELALIA
Date   Source Headline
30th Sep 20197:00 amRNSMATINS poster presentation at ESMO Congress
25th Sep 20199:13 amRNSHoldings in Company
23rd Sep 20197:08 amRNSInterim results
2nd Sep 20197:00 amRNSMATINS study selected for ESMO 2019
27th Aug 20197:00 amRNSResult of Open Offer and Further Subscription
19th Aug 20199:33 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSNotice of Interim Results
6th Aug 20191:53 pmRNSIssue of Equity
5th Aug 20197:00 amRNSSubscription and Open Offer
12th Jul 20197:00 amRNSMATINS study update
5th Jul 20199:00 amRNSPrice Monitoring Extension
4th Jul 20194:40 pmRNSSecond Price Monitoring Extn
4th Jul 20194:35 pmRNSPrice Monitoring Extension
4th Jul 20192:00 pmRNSPrice Monitoring Extension
4th Jul 20199:31 amRNSHoldings in Company
1st Jul 201912:10 pmRNSGrant of options
26th Jun 20197:00 amRNSPhase II INFORAAA study update
14th Jun 20197:00 amRNSFinal results from YODA study
28th May 201912:27 pmRNSResults of AGM
24th May 20199:32 amRNSAGM update, Board & management changes
22nd May 201912:51 pmRNSGrant of Options
21st May 20199:21 amRNSHolding(s) in Company
16th May 20199:16 amRNSHolding(s) in Company
14th May 20197:01 amRNSHoldings in Company
14th May 20197:00 amRNSShare Subscription and Issue of Equity
7th May 20197:05 amRNSNotice of AGM
7th May 20197:00 amRNSFinal Results for the year ended 31 December 2018
2nd May 20195:20 pmRNSStatement regarding Price Movement
2nd May 20192:05 pmRNSSecond Price Monitoring Extn
2nd May 20192:00 pmRNSPrice Monitoring Extension
29th Apr 20197:00 amRNSResults from the Japanese Phase III study
25th Apr 20194:09 pmRNSHolding(s) in Company
12th Apr 20191:20 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSFirst expansion cohort for MATINS trial part 2
10th Apr 201911:41 amRNSHolding(s) in Company
5th Apr 20197:00 amRNSNotice of Results
2nd Apr 20199:23 amRNSHoldings in Company
29th Mar 20197:00 amRNSHolding(s) in Company
28th Mar 201912:54 pmRNSResults of the Placing and Subscription
26th Mar 20193:31 pmRNSResult of Placing and Issue Price
26th Mar 20197:00 amRNSProposed Placing to raise approximately EUR 3m
21st Feb 20197:00 amRNSMATINS study update
13th Feb 20198:57 amRNSNew data published by Clinical Cancer Research
19th Dec 20187:00 amRNSTraumakine update - YODA results
14th Dec 201811:20 amRNSFirst patient dosed in phase I/II MATINS study
11th Dec 20184:26 pmRNSHolding(s) in Company
5th Dec 20187:00 amRNSPatient subgroup identified from INTEREST trial
3rd Dec 20187:00 amRNSFaron receives CTA approval for Clevegen
6th Nov 20183:52 pmRNSPDMR Dealings
23rd Oct 201811:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.